What companies are THNR's competitors?

Amplify Weight Loss Drug & Treatment ETF (THNR)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.

How does THNR compare to its peers?

The peer comparison table on this page shows Amplify Weight Loss Drug & Treatment ETF (THNR) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.

What sector does THNR operate in?

Amplify Weight Loss Drug & Treatment ETF (THNR) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

THNR

Amplify Weight Loss Drug & Treatment ETF

AMEX·Asset Management · Financial Services

$25.60$0.08−0.31%

After hours·$25.65+0.21%

Market cap$3.33M·Market closed·Jul 24 7:59 PM UTC

Frequently Asked Questions About THNR

What companies are THNR's competitors?: Amplify Weight Loss Drug & Treatment ETF (THNR)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does THNR compare to its peers?: The peer comparison table on this page shows Amplify Weight Loss Drug & Treatment ETF (THNR) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does THNR operate in?: Amplify Weight Loss Drug & Treatment ETF (THNR) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.

THNR

Amplify Weight Loss Drug & Treatment ETF

AMEX·Asset Management · Financial Services

$25.60$0.08−0.31%

After hours·$25.65+0.21%

Market cap$3.33M·Market closed·Jul 24 7:59 PM UTC

Peers


ION	ProShares S&P Global Core Battery Metals ETF	$46.90	$3.4M
CRED	Columbia Research Enhanced Real Estate ETF	$23.29	$3.4M
GEND	Genter Capital Dividend Income ETF	$13.05	$3.3M
CDIG	City Different Investments Global Equity ETF	$25.08	$3.1M
MCHS	Matthews China Discovery Active ETF MCHS	$41.56	$3.1M
BEDZ	AdvisorShares Hotel ETF	$36.24	$2.9M
EATZ	AdvisorShares Restaurant ETF	$27.20	$2.8M
KPRO	KraneShares 100% KWEB Defined Outcome January 2027 ETF	$26.77	$2.7M
DUKX	Ocean Park International ETF	$27.76	$2.7M
EAFG	Pacer Developed Markets Cash Cows Growth Leaders ETF	$25.03	$2.5M

Frequently Asked Questions About THNR

What companies are THNR's competitors?: Amplify Weight Loss Drug & Treatment ETF (THNR)'s closest competitors are the companies in the same industry classification, listed in the Peers to Research table on this page. Click any peer ticker to open its full analysis.
How does THNR compare to its peers?: The peer comparison table on this page shows Amplify Weight Loss Drug & Treatment ETF (THNR) alongside each peer with price, market cap, and key valuation / dividend metrics aligned side-by-side. Use it to spot relative outliers within the same business model.
What sector does THNR operate in?: Amplify Weight Loss Drug & Treatment ETF (THNR) operates in the Asset Management industry within the Financial Services sector. Peers are drawn from this classification — companies with similar revenue mix, cost structure, and customer demand drivers.